Financhill
Back

Cellectis SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Buy
62

CLLS
Cellectis SA

Last Price:
1.88
Seasonality Move:
2.21%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.63
Seasonality Move:
50.57%
Buy
62
Cellectis SA (CLLS) is a Buy

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.91. The Score for CLLS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • CLLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight buying pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 50.26 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.79 - 1.93) Buy
Bollinger Bands (100): (1.89 - 2.25) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 38.6 Sell
Chaikin Money Flow: -1006052 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.67 - 0.83) Sell
Bollinger Bands (100): (0.81 - 1.21) Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.93 Sell
20-day SMA: 1.86 Buy
50-day SMA: 1.99 Sell
200-day SMA: 2.36 Sell
8-day EMA: 1.91 Buy
20-day EMA: 1.9 Buy
50-day EMA: 1.97 Sell
200-day EMA: 2.24 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.69 Sell
20-day SMA: 0.74 Sell
50-day SMA: 0.86 Sell
200-day SMA: 1.12 Sell
8-day EMA: 0.68 Sell
20-day EMA: 0.74 Sell
50-day EMA: 0.84 Sell
200-day EMA: 1 Sell

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):